Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.99% | -31.78% | -20.16% | 422.25% | -58.86% |
| Total Depreciation and Amortization | -202.58% | 1.84% | 1.88% | 211.01% | -202.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -211.65% | 107.38% | -39.43% | 367.39% | -202.22% |
| Change in Net Operating Assets | 30.13% | -244.04% | 87.79% | -9,816.67% | -101.45% |
| Cash from Operations | -92.60% | -44.74% | 101.97% | 44.05% | -73.63% |
| Capital Expenditure | 18.61% | -34.83% | -36.22% | 39.13% | 3.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -40.00% | -- | -- | -- | -- |
| Divestitures | -- | -208.00% | 1,150.00% | 111.11% | -- |
| Other Investing Activities | 183.70% | -84.04% | -259.32% | -87.73% | 3,585.51% |
| Cash from Investing | 137.91% | -78.17% | -766.99% | 106.29% | -308.48% |
| Total Debt Issued | -56.02% | 1,256.32% | -68.78% | -83.40% | 10,393.75% |
| Total Debt Repaid | 73.82% | -1,981.82% | 108.06% | 5.93% | -155.46% |
| Issuance of Common Stock | -- | -- | -- | 43.75% | -66.67% |
| Repurchase of Common Stock | 45.56% | -191.92% | 70.39% | 44.71% | -2,648.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.05% | 1.04% | 0.26% | -3.49% | 1.32% |
| Other Financing Activities | -42.86% | 600.00% | 121.43% | -100.00% | -800.00% |
| Cash from Financing | -2.88% | 178.90% | 83.87% | -235.58% | 253.88% |
| Foreign Exchange rate Adjustments | -500.00% | -200.00% | 0.00% | 112.50% | -214.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -4,700.00% |
| Net Change in Cash | 408.50% | -85.57% | 234.52% | -286.73% | -69.17% |